When choosing your medication, do your research on how well they work. Both Mounjaro® and Wegovy® are highly effective for weight loss. People on Mounjaro have been shown to lose 20.2% of their body weight over 72 weeks, while those on Wegovy® lost 13.7%.(1)
A new higher dose of 7.2mg of Wegovy® has recently been discovered to achieve greater weight loss results than the standard dose, with nearly half of those taking it losing 20% or more of their body weight.(2) EU approval for the new Wegovy® higher dose is expected in early 2026. You won’t be able to buy it in the UK until after this and it will initially only be available privately before it becomes available on the NHS.
Nevolat is the generic equivalent of Saxenda and is usually cheaper than branded GLP-1 agonists like Wegovy®, and Mounjaro®, however Wegovy®, and Mounjaro® have been shown to perform better in clinical trials. A medicine that’s more effective can help you reach your target weight sooner, which reduces the cost of treatment over time. When used correctly along with a change in diet and increase in exercise, people can expect to lose around 5-10% of their starting body weight using Nevolat treatment.
In a clinical trial, two thirds of people taking liraglutide lost at least 5% of their body weight.(3)